PMID- 38405137 OWN - NLM STAT- MEDLINE DCOM- 20240227 LR - 20240306 IS - 1664-2392 (Print) IS - 1664-2392 (Electronic) IS - 1664-2392 (Linking) VI - 15 DP - 2024 TI - Association between urinary organophosphate ester metabolite exposure and thyroid disease risk among US adults: National Health and Nutrition Examination Survey 2011-2014. PG - 1329247 LID - 10.3389/fendo.2024.1329247 [doi] LID - 1329247 AB - BACKGROUND: Organophosphate esters (OPEs) may interfere with thyroid function, but the relationship between OPEs and thyroid disease remains unclear. This study aims to elucidate the relationship between OPEs exposure and thyroid disease risk in the general population in the United States. METHOD: Data were obtained from the 2011-2014 National Health and Nutrition Examination Survey cycle. All participants were tested for seven OPE metabolites in their urine and answered questions about whether they had thyroid disease through questionnaires. Logistic regression was employed to analyze the association between exposure to individual OPE metabolites and thyroid disease. Weighted Quantile Sum (WQS) regression modeling was utilized to assess exposure to mixed OPE metabolites and risk of thyroid disease. Bayesian kernel machine regression(BKMR) models to analyze the overall mixed effect of OPE metabolites. RESULT: A total of 2,449 participants were included in the study, 228 of whom had a history of thyroid disease. Bis(1,3-dichloro-2-propyl) phos (BDCPP), Diphenyl phosphate (DPHP) and Bis(2-chloroethyl) phosphate (BCEP) were the top three metabolites with the highest detection rates of 91.75%, 90.77% and 86.57%, respectively. In multivariate logistic regression models, after adjustment for confounding variables, individuals with the highest tertile level of BCEP were significantly and positively associated with increased risk of thyroid disease (OR=1.57, 95% CI=1.04-2.36), using the lowest tertile level as reference. In the positive WQS regression model, after correcting for confounding variables, mixed exposure to OPE metabolites was significantly positively associated with increased risk of thyroid disease (OR=1.03, 95% CI=1.01-1.06), with BCEP and DPHP having high weights. In the BKMR model, the overall effect of mixed exposure to OPE metabolites was not statistically significant, but univariate exposure response trends showed that the risk of thyroid disease decreased and then increased as BCEP exposure levels increased. CONCLUSION: The study revealed a significant association between exposure to OPE metabolites and an increased risk of thyroid disease, with BCEP emerging as the primary contributor. The risk of thyroid disease exhibits a J-shaped pattern, whereby the risk initially decreases and subsequently increases with rising levels of BCEP exposure. Additional studies are required to validate the association between OPEs and thyroid diseases. CI - Copyright (c) 2024 Lin, Lin, Wang, Xie, Li and Zhang. FAU - Lin, Yuxin AU - Lin Y AD - Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China. FAU - Lin, Ruipeng AU - Lin R AD - Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China. FAU - Wang, Weikang AU - Wang W AD - Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China. FAU - Xie, Manling AU - Xie M AD - Laboratory Center, The Major Subject of Environment and Health of Fujian Key Universities, School of Public Health, Fujian Medical University, Fuzhou, China. FAU - Li, Yun AU - Li Y AD - Food and Chemical Institute, Anhui Province Institute of Product Quality Supervision & Inspection, Hefei, China. FAU - Zhang, Qian AU - Zhang Q AD - Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20240209 PL - Switzerland TA - Front Endocrinol (Lausanne) JT - Frontiers in endocrinology JID - 101555782 RN - 0 (Flame Retardants) RN - 0 (Organophosphates) RN - 0 (Phosphates) RN - 0 (Esters) SB - IM MH - Adult MH - Humans MH - United States/epidemiology MH - Nutrition Surveys MH - Bayes Theorem MH - *Flame Retardants MH - Organophosphates/adverse effects/urine MH - *Thyroid Diseases/chemically induced/epidemiology MH - Phosphates MH - Esters PMC - PMC10884265 OTO - NOTNLM OT - Bayesian Kernel Machine Regression (BKMR) OT - Weighted Quantile Sum (WQS) regression OT - mixed exposure OT - nutrition surveys OT - organophosphate esters OT - thyroid diseases COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2024/02/26 06:44 MHDA- 2024/02/27 06:45 PMCR- 2024/01/01 CRDT- 2024/02/26 04:39 PHST- 2023/10/28 00:00 [received] PHST- 2024/01/22 00:00 [accepted] PHST- 2024/02/27 06:45 [medline] PHST- 2024/02/26 06:44 [pubmed] PHST- 2024/02/26 04:39 [entrez] PHST- 2024/01/01 00:00 [pmc-release] AID - 10.3389/fendo.2024.1329247 [doi] PST - epublish SO - Front Endocrinol (Lausanne). 2024 Feb 9;15:1329247. doi: 10.3389/fendo.2024.1329247. eCollection 2024.